Low-Dose Naltrexone International Purchase Legalities: What You Need to Know

At a glance

  • FDA-approved LDN product / None [1]
  • Approved naltrexone / 50 mg tablets; 380 mg monthly injection [4][5]
  • LDN doses in use / 0.5 to 6 mg a day, most often 4.5 mg [1]
  • Compounded drugs / Not FDA-approved; safety, effectiveness and quality not verified [6]
  • Imported unapproved drugs / Products from red-listed firms may be detained without physical examination; personal shipments follow separate procedures [2]

Is there an approved low-dose naltrexone product?

No. FDA has approved naltrexone as 50 mg tablets and as a 380 mg monthly gluteal injection [4][5]. LDN means 0.5 to 6 mg a day, most often 4.5 mg, prescribed off-label and supplied mainly as a compounded capsule or liquid [1]. A 2026 review of 105 studies, 15 of them randomized, calls the 4.5 mg dose empirically derived rather than evidence-based and notes that inconsistencies in compounded formulations add uncertainty [1].

What FDA says about compounded drugs and online buying

Compounded drugs are not FDA-approved, and FDA does not verify their safety, effectiveness or quality before they are marketed [6]. Poor compounding practices can leave a product contaminated or with too much or too little active ingredient [6]. People buying compounded drugs online may not know who made the product or whether the compounder is properly licensed and regulated [6]. Under the patient-specific-prescription pathway, federal law requires a valid prescription; FDA also describes outsourcing facilities that may distribute compounded drugs in response to a health-care-provider order [7].

What happens at the U.S. border

FDA Import Alert 66-41 covers unapproved new drugs, which FDA says have not been reviewed for safety or effectiveness [2]. It allows field divisions to detain identified products from firms on its red list without physical examination [2]. For personal-importation shipments, it directs staff to follow the Regulatory Procedures Manual guidance. It says commercial or promotional shipments, and products subject to detention without examination, are generally not amenable to enforcement discretion [2].

Naltrexone is not named on FDA's list of bulk drug substances that may present significant safety risks in compounding (page current as of 04/22/2026) [3]. That does not make an imported finished product FDA-approved.

Opioid precautions still apply

The naltrexone labels were written for 50 mg tablets and 380 mg injections and give no guidance on LDN doses [1][4]. They list as contraindications patients receiving opioid analgesics and patients currently dependent on opioids, including those maintained on methadone or buprenorphine. The opioid-analgesic contraindication is written without any dose exception [4][5]. In an opioid-dependent person, naltrexone can precipitate withdrawal severe enough to require hospitalization [4]. The labels recommend a minimum of 7 to 10 opioid-free days beforehand [4][5].

The domestic route

HealthRX.com offers low-dose naltrexone by prescription.

Frequently asked questions

Is low-dose naltrexone FDA-approved?
No. FDA has approved naltrexone as 50 mg tablets and a 380 mg monthly injection, neither at LDN doses [4][5][1]. LDN is 0.5 to 6 mg a day, most often 4.5 mg, and is commonly supplied by compounders [1].
Can an imported LDN order be stopped at the border?
FDA's import alert allows detention without physical examination of identified products from firms on its red list, and it directs personal shipments to separate personal-importation procedures [2].
Does FDA check compounded naltrexone bought online?
No. FDA says compounded drugs are not FDA-approved and that it does not verify their safety, effectiveness or quality; buyers may not know who made the product [6].
Can low-dose naltrexone be taken with opioid pain medicine?
The naltrexone labels list patients receiving opioid analgesics as a contraindication, with no dose exception, and they give no guidance on LDN doses. They also say starting too soon after opioids can precipitate withdrawal needing hospital care [4][5].
Is there an FDA-approved 4.5 mg naltrexone tablet?
No. FDA has approved no low-dose naltrexone product; LDN is commonly prepared by compounding pharmacies [1][6].

References

  1. Low-Dose Naltrexone: What is the Evidence? A Narrative Review - PMC. Low-Dose Naltrexone: What is the Evidence? A Narrative Review - PMC
  2. Import Alert 66-41. Import Alert 66-41
  3. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA
  4. U.S. National Library of Medicine, DailyMed. Naltrexone hydrochloride tablets USP 50 mg (generic), SpecGx prescribing information. Naltrexone hydrochloride tablets USP 50 mg (generic), SpecGx label
  5. U.S. National Library of Medicine, DailyMed. Vivitrol (naltrexone for extended-release injectable suspension), Alkermes prescribing information. Vivitrol (naltrexone for extended-release injectable suspension), Alkermes label
  6. Compounding and the FDA: Questions and Answers | FDA. Compounding and the FDA: Questions and Answers | FDA
  7. Human Drug Compounding Laws | FDA. Human Drug Compounding Laws | FDA
Evidence overview for Low-Dose Naltrexone International Purchase Legalities: What You Need to Know